Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.
Martin S, Smolders S, Van den Haute C, Heeman B, van Veen S, Crosiers D, Beletchi I, Verstraeten A, Gossye H, Gelders G, et al. Acta Neuropathol. 2020 Jun; 139(6):1001-1024. Epub 2020 Mar 14.